Compounds > angiotensin ii
Page last updated: 2024-08-22

angiotensin ii and arsenic trioxide

angiotensin ii has been researched along with arsenic trioxide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, WF; Ding, XQ; Dong, CJ; Li, YY; Liu, MT; Liu, SK; Liu, Y; Liu, YX; Qiu, F; Shao, XQ; Wang, JX; Wu, D; Yang, BF; Zhang, LL; Zhao, D1
Chu, WF; Dong, CJ; Li, D; Li, JT; Li, YY; Liu, MT; Liu, SK; Liu, Y; Liu, YX; Mu, W; Nie, D; Qiu, F; Tian, W; Wang, JX; Wang, XF; Wu, D; Yang, BF; Yang, J; Zhao, D1

Other Studies

2 other study(ies) available for angiotensin ii and arsenic trioxide

ArticleYear
Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2017, 03-01, Volume: 25, Issue:3

    Topics: Angiotensin II; Animals; Arsenic Trioxide; Arsenicals; Collagen; Fibrosis; Gene Silencing; Mice; Myocardium; Myofibroblasts; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Protein Binding; Sumoylation; Transcription Factors; Transforming Growth Factor beta1; Ubiquitin-Conjugating Enzymes; Ubiquitin-Protein Ligases

2017
Arsenic trioxide and angiotensin II have inhibitory effects on HERG protein expression: Evidence for the role of PML SUMOylation.
    Oncotarget, 2017, Jul-11, Volume: 8, Issue:28

    Topics: Angiotensin II; Animals; Arsenic Trioxide; Arsenicals; Cyclic AMP-Dependent Protein Kinases; ERG1 Potassium Channel; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Intranuclear Inclusion Bodies; Mice; Models, Biological; Myocytes, Cardiac; NIMA-Interacting Peptidylprolyl Isomerase; Oxides; Promyelocytic Leukemia Protein; Sumoylation; Transforming Growth Factor beta1; Ubiquitin-Conjugating Enzymes

2017